A retrospective analysis using Monte Carlo simulation to evaluate recommended ceftazidime dosing regimens in healthy volunteers, patients with cystic fibrosis, and patients in the intensive care unit-Reference-Cited by-同舟云学术

A retrospective analysis using Monte Carlo simulation to evaluate recommended ceftazidime dosing regimens in healthy volunteers, patients with cystic fibrosis, and patients in the intensive care unit

Published:2005-06 Issue:6 Volume:27 Page:762-772
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Mouton Johan W.,Punt Nieko,Vinks Alexander A.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference42 articles.

1. Use of pharmacokinetics-pharmacodynamics and Monte-Carlo simulation as decision support for the reevaluation of NCCLS cephem susceptibility breakpoints for Enterobacteriaceae;Ambrose,2004

2. European Committee on Antimicrobial Susceptibility Testing. Clinical breakpoints and epidemiological cut-off. Available at: www.eucast.org. Accessed January 15, 2005.

3. Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men;Craig;Clin Infect Dis,1998

4. Animal model pharmacokinetics and pharmacodynamics: A critical review;Andes;Int J Antimicrob Agents,2002

5. The use of Monte Carlo simulation to examine pharmacodynamic variance of drugs: Fluoroquinolone pharmacodynamics against Streptococcus pneumoniae;Ambrose;Diagn Microbiol Infect Dis,2000

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining standard and high dosages for β-lactam agents administered by intermittent, prolonged or continuous infusion: a PK/PD simulation study;Journal of Antimicrobial Chemotherapy;2023-10-05

2. Population Pharmacokinetics and Probability of Target Attainment of Different Dosing Regimens of Ceftazidime in Critically Ill Patients with a Proven or Suspected Pseudomonas aeruginosa Infection;Antibiotics;2021-05-21

3. Population Pharmacokinetics and Dose Optimization of Ceftazidime and Imipenem in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease;Pharmaceutics;2021-03-27

4. Pharmacokinetic and Pharmacodynamic Optimization of Antibiotic Therapy in Cystic Fibrosis Patients: Current Evidences, Gaps in Knowledge and Future Directions;Clinical Pharmacokinetics;2021-01-24

5. Antibiotics in Adult Cystic Fibrosis Patients: A Review of Population Pharmacokinetic Analyses;Clinical Pharmacokinetics;2021-01-15